TD Private Client Wealth LLC Grows Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

TD Private Client Wealth LLC boosted its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 34.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,290 shares of the company’s stock after buying an additional 593 shares during the quarter. TD Private Client Wealth LLC’s holdings in Bath & Body Works were worth $89,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of BBWI. FMR LLC boosted its holdings in Bath & Body Works by 17,496.5% in the third quarter. FMR LLC now owns 2,516,127 shares of the company’s stock valued at $80,315,000 after purchasing an additional 2,501,828 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Bath & Body Works by 13.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,704,625 shares of the company’s stock worth $66,088,000 after buying an additional 195,813 shares during the last quarter. Erste Asset Management GmbH boosted its holdings in shares of Bath & Body Works by 0.3% in the 4th quarter. Erste Asset Management GmbH now owns 1,585,460 shares of the company’s stock valued at $61,546,000 after buying an additional 5,035 shares in the last quarter. Forest Avenue Capital Management LP grew its position in shares of Bath & Body Works by 19.1% in the 3rd quarter. Forest Avenue Capital Management LP now owns 1,467,763 shares of the company’s stock valued at $46,851,000 after buying an additional 235,173 shares during the last quarter. Finally, Verition Fund Management LLC raised its stake in Bath & Body Works by 111.8% during the 3rd quarter. Verition Fund Management LLC now owns 1,345,777 shares of the company’s stock worth $42,957,000 after acquiring an additional 710,333 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Trading Down 0.7 %

NYSE BBWI opened at $32.19 on Wednesday. The stock has a market capitalization of $6.90 billion, a price-to-earnings ratio of 7.85, a PEG ratio of 0.92 and a beta of 1.89. The business’s 50 day moving average is $35.52 and its two-hundred day moving average is $34.03. Bath & Body Works, Inc. has a 12-month low of $26.21 and a 12-month high of $52.99.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. The firm had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. Equities analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works declared that its Board of Directors has authorized a stock repurchase program on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to repurchase up to 6.4% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s management believes its stock is undervalued.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.49%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works’s dividend payout ratio (DPR) is 21.98%.

Analyst Upgrades and Downgrades

BBWI has been the subject of several research analyst reports. JPMorgan Chase & Co. set a $47.00 price objective on shares of Bath & Body Works in a research note on Thursday, February 27th. Robert W. Baird raised their price target on Bath & Body Works from $45.00 to $47.00 and gave the stock an “outperform” rating in a research note on Friday, February 28th. Argus reiterated a “hold” rating on shares of Bath & Body Works in a research note on Friday, January 10th. Raymond James reissued an “outperform” rating and issued a $46.00 price objective (up from $42.00) on shares of Bath & Body Works in a report on Tuesday, February 25th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Five equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $45.06.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.